Cat. No.: X24-08-YM358
Metabolism inhibitor, Clarithromycin, Purity ≥98%
Synonym: 81103-11-9; A-56268; TE-03; Crixan; Claritt; Clarac; Biaxin; Klaricid; Klacid; Klaram; Klabax; Claripen; Clarem; Claridar; Fromilid; Clacid; Clacee; Vikrol; Infex; Clariwin; Resclar; Ranbaxy; Clarihexal; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
- MDL: MFCD00865140
- CAS Number: 81103-11-9
- Compound CID: 84029
Product Size
100 mg; 200 mg; 500 mg; 1000 mg
Properties
Description
Clarithromycin, soluble in warmed DMSO and insoluble in water and ethanol, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of metabolism by inhibiting cytochrome P450.
Molecular Formula
C38H69NO13
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO (warmed): 25 mg/mL (33.42 mM); Water: insoluble; Ethanol: insoluble
Applications
Clarithromycin is a metabolism inhibitor that plays a key role in infections caused by bacteria, including respiratory infections, skin infections, and Helicobacter pylori infections.
Related Products
- Cytochrome P450 inhibitor, Abiraterone, Purity ≥98%
- Cytochrome P450 inhibitor, Alizarin, Purity ≥98%
- Cytochrome P450 inhibitor, Apigenin, Purity ≥98%
- Cytochrome P450 inhibitor, Avasimibe, Purity ≥98%
- Cytochrome P450 inhibitor, Baicalein, Purity ≥98%
- Metabolism inhibitor, Chloramphenicol, Purity ≥98%
